Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

1.20

Today's Change

-0.015 (1.22%)

Day's Change

1.20 - 1.22

Trading Volume

3,303,707

Overview

Market Cap

435 Million

Shares Outstanding

361 Million

Avg Volume

2,932,820

Avg Price (50 Days)

1.72

Avg Price (200 Days)

1.92

PE Ratio

-1.54

EPS

-0.78

Earnings Announcement

06-Nov-2024

Previous Close

1.22

Open

1.22

Day's Range

1.2 - 1.225

Year Range

0.92 - 3.73

Trading Volume

3,322,408

Price Change Highlight

1 Day Change

-1.23%

5 Day Change

-40.05%

1 Month Change

-28.70%

3 Month Change

-29.12%

6 Month Change

-30.75%

Ytd Change

-24.21%

1 Year Change

-6.59%

3 Year Change

-75.75%

5 Year Change

-69.49%

10 Year Change

-88.05%

Max Change

-99.08%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment